BLA for subcutaneous formulation of Leqembi® accepted in China

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for the subcutaneous formulation (subcutaneous autoinjector: SC-AI) of ...
Nasdaq

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Pemetrexed and Platinum Chemotherapy as First-Line Therapy ...

SAN FRANCISCO and SUZHOU, China, Feb. 2, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...
Yahoo

China’s fusion reactor to achieve high fueling with cryogenic pellet injection

Scientists in China have made a new system for fueling the tokamak device. The continuous cryogenic pellet injection system overcomes challenges related to cryogenic ice formation and many others.
FiercePharma

Reportlinker Adds Market of Paclitaxel Injection in China

NEW YORK, Aug. 19 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: What's more, paclitaxel injection has to get into hospitals through the ...
Business Wire

Research and Markets: Market of Paclitaxel Injection in China

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/f3da95/market_of_paclitax) has announced the addition of the "Market of ...

China's First Domestic Anti-CTLA-4 Monoclonal Antibody, Innovent's TABOSUN® (Ipilimumab N01 Injection) Received NMPA Approval

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, ...
Nasdaq

Innovent and Lilly Jointly Announce the China NMPA Approval of TYVYT® (sintilimab injection) in Combination with Gemcitabine and Platinum Chemotherapy as First-Line Therapy ...

SAN FRANCISCO and SUZHOU, China, June 3, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes ...